NS Pharma, Inc.
Takashi Hosono is an accomplished professional with extensive experience in the pharmaceutical industry. Takashi has held various project management roles at Astellas Pharma and TEIJIN PHARMA LIMITED, leading the development of new drugs for rare diseases, vasomotor symptoms, neurological disorders, muscular diseases, and osteoporosis. Takashi also has a strong educational background with a Master's degree in Engineering Science and additional certifications in Conscious Leadership and Business Administration. Currently, Takashi serves as the Associate Director of Clinical Research at NS Pharma, Inc.
This person is not in the org chart
NS Pharma, Inc.
2 followers
NS Pharma, Inc. (NSP) located in Paramus New Jersey is a subsidiary of Nippon Shinyaku Co., Ltd. Founded in 1999 in the United States, NSP is engaged in clinical studies and partnering with global pharmaceutical companies, venture companies and research institutes. NSP serves as a contact point for connecting Japan/Asia and the world, developing drug candidates invented in Japan and out-license them to the world. From the world to Japan/Asia, NSP in-license promising drug candidates to the Japanese/Asian Markets. In coordination with parent company, Nippon Shinyaku, Co., Ltd., NSP will first and foremost develop and supply safe and highly effective pharmaceuticals through clinical studies. NSP aims to be an indispensable entity in the healthcare industry in line with the guidelines for action “Challenge”, “Speed”, and “Investigation”.